Hold MDLZ at neutral sizing with pre-committed -1.0%/5-session alpha-loss trim trigger
Hold with pre-committed, tightened alpha-loss trim trigger — capturing the structural-floor defense without underwriting unconfirmed catalysts, while preventing the silent alpha bleed that has damaged three consecutive prior Holds averaging -0.87% alpha against SPY.
| Position | Action |
|---|---|
| Current position | Maintain neutral sizing (no pre-emptive trim or addition) |
| MDLZ underperforms SPY by -1.0% over any 5-session rolling window | Automatically trim 15% of position into strength |
MDLZ is a defensive compounder at a technical inflection point, with macro tailwinds (defensive rotation in hawkish regime), input-cost tailwinds (cocoa cycle stabilizing), and product-cycle tailwinds (premium innovation) converging, requiring only the cocoa cycle to turn rather than a recession for the bull case to materialize.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 58.93 | bullish |
| close_50_sma | 62.10 | bearish |
| close_10_ema | 61.19 | bearish |
| rsi | 39.65 | bearish |
| macd | -0.42 | bearish |
| macds | -0.23 | bearish |
| macdh | -0.18 | neutral |
| boll | 61.69 (mid) / 63.18 (ub) / 60.20 (lb) | bullish |
| vwma | 61.51 | bearish |
| atr | 1.20 | neutral |
| volume | 5,513,548 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close below $58.50 on above-average volume
Then: Trim to Underweight; downside target $54-55
Q1 FCF weakness is structurally seasonal (inventory build for holiday season) rather than a red flag, with TTM coverage sufficient and the company signaling cocoa stabilization through executive appointment.
↩ rebuts: “Bear treating Q1 as representative of annual cash flow risk”
EV: +17% to $72-75 · concedes: Q1 is always MDLZ's weakest cash flow quarter due to seasonal inventory build; 10% recession odds exist and bear needs this to be right; 10-year yields at highest since 2007, 30-year at 2004 highs, mortgage rates at 7.5%; Hawkish duration shock could compress multiples from 22x to 19x; If FCF coverage improves to 1.5x+ requires cocoa cycle to turn and modest margin expansion
MDLZ is a "Show Me" story requiring five simultaneous catalysts (cocoa cycle turn, rate stabilization, sector floor, margin expansion, technical confirmation) versus a single break point at the 200 SMA $58.93—making the risk/reward asymmetric to the downside at current entry levels.
EV: -10% to -14% (bear-case target $52-54) · concedes: The histogram is decelerating (from -0.289 to -0.18); RSI at 39.65 is getting closer to oversold territory; Q1 2026 revenue did grow 12.8% YoY; The dividend has grown every year for a decade; Gross margin held at 31.2% through the cocoa shock
→ vs conservative: MACD bearish cross on September 18th with RSI at 39.65 is the weakest leg of the bearish argument because the MACD histogram is decelerating (negative 0.18 vs September 8th trough of negative 0.289), indicating momentum exhaustion not fresh bearish impulse
→ vs conservative: Bollinger lower band touch at 60.20 after capitulation event on 17.7M volume followed by lightest volume day of the decline (5.5M) is one of the cleanest technical setups for a bounce, not permission to do nothing
→ vs conservative: Symmetric risk/reward framework is broken: path back to 50 SMA at 62.10 is not a 50/50 coin flip but a 65/70 percent base-rate mean reversion trade
→ vs conservative: Q1 2026 FCF of 155M is seasonal working capital build noise, not structural deterioration; Q4 2025 printed 1.999B and TTM is 2.25B versus 2.5B dividend obligation
→ vs conservative: Macro regime of HIGHER FOR LONGER with beta 0.40 and 3.42 percent yield is exactly where defensive exposure should be built, not a reason to sit in cash
→ vs neutral: Balance does not mean equally weighted in the decision tree; when macro, structure, catalysts, and price action all align simultaneously, balance looks like aggressive accumulation, not waiting for confirmation
→ vs conservative: Sitting in cash waiting for a 200 SMA test that may never come while the defensive rotation runs is how you underperform for six months; HOLD is actually the high-risk trade because the highest risk is missing the move, not taking it
Support: 58.93 · 60.2 · 60 | Resistance: 61.19 · 61.69 · 62.1 · 63.18
MDLZ exhibits a short-term correction within a long-term uptrend — price is testing the lower Bollinger band at 60.20 while remaining above the critical 200 SMA support of 58.93. Bearish signals dominate the medium-term (price below 50 SMA at 62.10, bearish MACD crossover) but momentum deceleration and the capitulation volume spike on Sep 18 (17.7M shares) suggest selling exhaustion. A tactical bounce to the Boll mid at 61.69 is the base case; a break below 200 SMA would signal trend regime change. The rating is HOLD existing longs with stops under 58.50–58.90.
Market Cap
$76.90B
Revenue (TTM)
$39.67B
Gross Profit
$12.36B
EBITDA
$6.08B
Net Income
$3.52B
Operating Margin
21.98%
Net Profit Margin
8.86%
ROE
13.34%
ROA
4.12%
P/E (TTM)
22.07
Forward P/E
17.93
PEG Ratio
0.90
Price/Book
2.90
Book Value per Share
$20.80
EV/EBITDA
~15.8x
Dividend Yield
3.42%
Quarterly Dividend
~$0.625/share
Annual Dividend
~$2.5B
Total Assets
$71.12B
Total Equity
$25.75B
Goodwill + Intangibles
$43.76B
Total Debt
$21.62B
Net Debt
$19.50B
Long-Term Debt
$15.47B
Debt/Equity
82.6%
Net Debt/EBITDA
~3.2x
Current Ratio
0.60
Working Capital
-$10.76B
Cash & Equivalents
$1.52B
Inventory
$4.08B
Receivables
$5.38B
FCF (TTM)
$2.25B
Dividend Coverage (FCF)
~0.9x
CapEx (TTM)
~$1.4B
Beta
0.40
52-Week Range
$51.20 – $66.65
52-Week Position
Near High
Q1 2026 Revenue
$10.50B
Q2 2026 Revenue
$10.08B
Forward EPS Growth
~+23% vs TTM
Strengths
Concerns
MDLZ is a high-quality defensive compounder with iconic brands (Oreo, Cadbury, Milka, Trident), ~22% operating margins, and a 3.42% dividend yield backed by a 10+ year track record of annual increases. The stock trades near its 52-week high ($66.65) with reasonable forward valuation (PEG 0.9, forward P/E 17.9) but faces three key caution flags: recent FCF has weakened materially ($155M in Q1 2026), dividend coverage by FCF is thin (~0.9x TTM), and Net Debt/EBITDA stands at 3.2x with $5.56B in short-term debt obligations.
Macro: Hawkish duration shock with no recession priced in: 10Y U.S. Treasury yield reached highest level since 2007, 30Y at highest since 2004; Polymarket 'No Fed rate cuts in 2026' at 97% (+1.4pp WoW) with all other cut contracts at 0%; 'U.S. recession by end of 2026' at only 10% (+1pp WoW); mortgage rates creeping toward 7.5%; equities notched weekly gains despite bond turmoil (late-cycle divergence). Oil spiked mid-week on Iran/Hormuz tensions then eased Friday on tentative Hormuz deal. Consumer staples sector treated as contrarian value idea—PepsiCo trading near 52-week lows, down ~7% YTD with 41% upside target cited.